Technological studies on the development of the corrected dosage form base

Authors

  • Олександр Олександрович Шмалько National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002, Ukraine
  • Лілія Іванівна Вишневська National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002, Ukraine
  • Володимир Костянтинович Яковенко National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002, Ukraine
  • Юрій Георгійович Пісковацький NPFK "Aime" Kharkivskyh diviziy, 20, Kharkiv, Ukraine, 61091, Ukraine

DOI:

https://doi.org/10.15587/2519-4852.2016.87540

Keywords:

combined syrup, base, thickeners, excipients, herbal compound, composition, technology

Abstract

Aim. The aim was to substantiate and to study excipients, in particular thickeners, in development of the base composition of the combined syrup containing herbal compound, applied for the treatment of hepatobiliary system and gallbladder.

Methods. Analytical, retrospective, logical methods were used for the literature data analysis; marketing analysis – for research of the national market pharmaceutical segment in relation to excipients in syrups studies; physical and organoleptic methods.

Results. According to the given research results, substances, used as excipients in syrups production and registered in Ukraine, were determined. It was found, that saccharose (38%), as well as sorbitol and lactulose (19% each), and among synthetic compounds Sodium saccharin (13%) are most commonly used as sweeteners in syrups. Moreover, the use of saccharose in syrups by the national manufacturers far exceeds its use by the international producers (75% and 25%, respectively). The most commonly used thickeners are cellulose derivatives (HEC and CMC – 60% and 34%, respectively) and gums (23%). Only 25% of the national manufacturers use thickeners as excipients.

Results have shown that the samples 3 and 4 with HEC concentration 0,3 and 0,4% had poor consistency as for syrup. Syrup sample 5 (with HEC content 0,5 ± 0,2 %) is a viscous liquid, which is dosed easily, with mass dosing deviation no more than ± 3 %, that meets the SPhU requirements. Therefore, according to the dynamic viscosity and organoleptic properties indexes, the concentration of hydroxyethyl cellulose was determined for the developed syrup – 0,5 ± 0,1 %.

Conclusion. The advisability of using of the thickener – hydroxyethyl cellulose in concentration of 0,5%  – in the combined syrup development was theoretically substantiated and experimentally proved

Author Biographies

Олександр Олександрович Шмалько, National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002

Applicant

Department of pharmacy drug technology

Лілія Іванівна Вишневська, National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Professor

Department of pharmacy drug technology

Володимир Костянтинович Яковенко, National University of Pharmacy Pushkinskaya str., 53, Kharkiv, Ukraine, 61002

Doctor of Pharmaceutical Sciences, Associate Professor

Department of Industrial Pharmacy and the economy

Юрій Георгійович Пісковацький, NPFK "Aime" Kharkivskyh diviziy, 20, Kharkiv, Ukraine, 61091

PhD

director

References

  1. Derzhavna Farmakopeja Ukraini (2001). Derzhavne pidpriemstvo «Naukovo-ekspertnij farmakopejnij centr». Kharkiv: Rireg, 520.
  2. Sineva, T. D. (2008). Farmakologicheskie aspekty primenenija sorbita v kachestve vspomogatel'nogo veshhestva v lekarstvennyh preparatah dlja detej. Voprosy biologicheskoj, medicinskoj, i farmacevticheskoj himii, 2, 41–45.
  3. Nikolova, E. (2013). Cultivation of natural sweetener stevia (stevia rebaudiana b.) in central bulgaria – plovdiv region. New knowledge journal of science, 207–216.
  4. Shmal'ko, A. A., Vishnevskaja, L. I., Megalinskij, V. A. (2015). Issledovanija po vyboru nesaharnoj osnovy dlja rastitel'nogo siropa. Respublikanskij nauchnyj zhurnal «Vestnik», 4 (73), 116–119.
  5. Kuznecov, A. V., Kuznecov, A. A. (2011). Korrigenty vkusa v proizvodstve lekarstvennyh preparatov. Farmacija, 2, 53–57.
  6. Percev, І. M., Dmitrіevs'kij, D. І., Ribachuk, V. D. (2010). Dopomіzhnі rechovini v tehnologіi lіkіv: vpliv na tehnologіchnі, spozhivchі, ekonomіchnі harakteristiki і terapevtichnu efektivnіst. Kharkiv: Zolotі storіnki, 600.
  7. Zhoglo, F., Voznjak, V., Popovich, V., Bogdan, Ja. (1996). Dopomіzhnі rechovini ta ih zastosuvannja v tehnologіi lіkars'kih form. Lvіv, 95.
  8. Kamaeva, S. S., Merkureva, G. Ju., Stepanov, D. V. (2012). Razrabotka siropa ambroksola: vybor vspomogatel'nyh veshhestv. Zdorov'e – osnova chelovecheskogo potenciala. Problemy i puti ih reshenija, 7 (2), 846–848.
  9. Ahmed-Belkacem, A., Ahnou, N., Barbotte, L., Wychowski, C., Pallier, C., Brillet, R. et. al. (2010). Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase. Gastroenterology, 138 (3), 1112–1122. doi: 10.1053/j.gastro.2009.11.053
  10. Coon, J. T., Ernst, E. (2004). Complementary and alternative therapies in the treatment of chronic hepatitis C: a systematic review. Journal of Hepatology, 40 (3), 491–500. doi: 10.1016/j.jhep.2003.11.014
  11. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases (2009). Journal of Hepatology, 51 (2), 237–267. doi: 10.1016/j.jhep.2009.04.009
  12. Bray, G. A., Nielsen, S. J., Popkin, B. M. (2004). Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. The American Journal of Clinical Nutrition, 79 (4), 537–543.
  13. European Pharmacopoeia (2004). Council of Europe. Strasbourg, 4800–4801.

Downloads

Published

2016-12-28

How to Cite

Шмалько, О. О., Вишневська, Л. І., Яковенко, В. К., & Пісковацький, Ю. Г. (2016). Technological studies on the development of the corrected dosage form base. ScienceRise: Pharmaceutical Science, (4 (4), 4–8. https://doi.org/10.15587/2519-4852.2016.87540

Issue

No. 4 (4) (2016)

Section

Pharmaceutical Science

License

Copyright (c) 2016 Олександр Олександрович Шмалько, Лілія Іванівна Вишневська, Володимир Костянтинович Яковенко, Юрій Георгійович Пісковацький

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our journal abides by the Creative Commons Attribution 4.0 International License copyright rights and permissions for open access journals.

Authors, who are published in this journal, agree to the following conditions:

1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.

 2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.

3. Authors have the right to store the final accepted version of the article in an institutional, thematic, or any other repository to ensure visibility and accessibility.